| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2003;41:794.)
© 2003 American Heart Association, Inc.
Scientific Contributions |
Mediates Norepinephrine-Induced Phospholipase D Activation and Cell Proliferation in VSMC
From the Department of Pharmacology and Vascular Biology Center of Excellence, College of Medicine, The University of Tennessee Health Science Center, Memphis.
Correspondence to Kafait U. Malik, PhD, DSc, Professor of Pharmacology, College of Medicine, The University of Tennessee, Memphis, 874 Union Ave, Memphis, TN 38163. E-mail kmalik{at}utmem.edu
Norepinephrine (NE) stimulates phospholipase D (PLD) activity and cell proliferation in vascular smooth muscle cells (VSMCs). The objective of this study was to determine the contribution of PKC-
to NE-induced PLD activation and cell proliferation in VSMCs. PLD activity was measured by the formation of [3H]phosphatidylethanol in VSMCs labeled with [3H]oleic acid and exposed to ethanol. A high basal PLD activity was detected, and NE increased PLD activity over basal by 70%. This increase was abolished by the broad-range PKC inhibitor Ro 31-8220 (1 µmol/L, 30 minutes) and myristoylated PKC-
pseudosubstrate peptide inhibitor (25 µmol/L, 1 hour). Transfection of VSMCs with PKC-
antisense, but not sense, oligonucleotides, which reduced PKC-
protein level and basal PLD activity, caused a 92% decrease in NE-induced PLD activation. NE-induced increase in PLD activity was also reduced by 61% in cells transfected with kinase-deficient FLAG-T410A-PKC-
plasmid but not in those transfected with wild-type PKC-
. NE increased immunoprecipitable PKC-
activity and phosphorylation, reaching a maximum at 2 and 5 minutes, respectively. NE-induced increase in PKC-
activity was inhibited by Ro 31-8220 and by the pseudosubstrate inhibitor. Treatment of VSMCs for 48 hours with PKC-
antisense, but not sense, oligonucleotides also inhibited basal and NE-stimulated cell proliferation by 54% and 57%, respectively, as measured by [3H]thymidine incorporation. The inhibitor of PLD activity n-butanol, but not its inactive analog tert-butanol, also reduced the basal and blocked NE-induced cell proliferation. These data suggest that PKC-
mediates PLD activation and cell proliferation elicited by NE in rabbit VSMCs.
Key Words: phospholipase D norepinephrine muscle, smooth, vascular protein kinases cell proliferation
This article has been cited by other articles:
![]() |
Z. Li, C. Yu, Y. Han, H. Ren, W. Shi, C. Fu, D. He, L. Huang, C. Yang, X. Wang, et al. Inhibitory effect of D1-like and D3 dopamine receptors on norepinephrine-induced proliferation in vascular smooth muscle cells Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2761 - H2768. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Xiang, Y. Zhang, Y.M. Li, K. Zhang, Y.Y. Zhang, L.L. Wu, and G.Y. Yu Effects of Phenylephrine on Transplanted Submandibular Gland. J. Dent. Res., December 1, 2006; 85(12): 1106 - 1111. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Benitez-Rajal, M.-J. Lorite, A. D. Burt, C. P. Day, and M. G. Thompson Phospholipase D and extracellular signal-regulated kinase in hepatic stellate cells: effects of platelet-derived growth factor and extracellular nucleotides. Am J Physiol Gastrointest Liver Physiol, November 1, 2006; 291(5): G977 - G986. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Parmentier, C. Zhang, A. Estes, S. Schaefer, and K. U. Malik Essential role of PKC-{zeta} in normal and angiotensin II-accelerated neointimal growth after vascular injury Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1602 - H1613. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Barreiro Arcos, G. Gorelik, A. Klecha, A. M. Genaro, and G. A. Cremaschi Thyroid hormones increase inducible nitric oxide synthase gene expression downstream from PKC-{zeta} in murine tumor T lymphocytes Am J Physiol Cell Physiol, August 1, 2006; 291(2): C327 - C336. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gayral, P. Deleris, K. Laulagnier, M. Laffargue, J.-P. Salles, B. Perret, M. Record, and M. Breton-Douillon Selective Activation of Nuclear Phospholipase D-1 by G Protein-Coupled Receptor Agonists in Vascular Smooth Muscle Cells Circ. Res., July 21, 2006; 99(2): 132 - 139. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Parmentier, Z. Pavicevic, and K. U. Malik ANG II stimulates phospholipase D through PKC{zeta} activation in VSMC: implications in adhesion, spreading, and hypertrophy Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H46 - H54. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Li, C. Zhang, S. Schaefer, A. Estes, and K. U. Malik ANG II-induced neointimal growth is mediated via cPLA2- and PLD2-activated Akt in balloon-injured rat carotid artery Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2592 - H2601. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Kim, J. H. Kim, M. Ohba, P.-G. Suh, and S. H. Ryu Novel Functions of the Phospholipase D2-Phox Homology Domain in Protein Kinase C{zeta} Activation Mol. Cell. Biol., April 15, 2005; 25(8): 3194 - 3208. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |